The Budesonide/Formoterol Shortage: Where Things Stand Right Now

If you've had trouble finding Budesonide/Formoterol — sold as Symbicort or the generic Breyna — over the past couple of years, you're not alone. Supply issues with this essential asthma and COPD inhaler have affected thousands of patients across the country since 2023.

But as we head through 2026, the picture is changing. Here's the latest on the Budesonide/Formoterol shortage, what it costs now, and how to make sure you can fill your prescription.

Is Budesonide/Formoterol Still in Shortage?

As of early 2026, Budesonide/Formoterol is not on the FDA's official drug shortage list. That's good news — it means the agency considers overall supply to be adequate at the national level.

However, "not in shortage" at the national level doesn't always mean your local pharmacy has it in stock. Localized supply gaps still occur, particularly:

• During fall and winter when respiratory illnesses spike demand for inhalers
• In regions with fewer pharmacy options or more limited wholesaler distribution
• At large chain pharmacies that face allocation limits from their wholesalers

The situation is significantly better than 2023–2024, but it hasn't completely normalized everywhere. If your pharmacy is out, it's worth checking other options before assuming there's a widespread problem.

A Brief History: Why Was Budesonide/Formoterol Hard to Find?

Several factors converged to create the shortage over the past few years:

• 2023: Post-pandemic supply chain disruptions hit inhaler manufacturing hard. The specialized manufacturing process for metered-dose inhalers — involving pressurized canisters and propellants — made them particularly vulnerable. Reports of Symbicort being out of stock at pharmacies increased significantly.
• 2024: Intermittent shortages continued. The FDA monitored the situation but Symbicort was not placed on the critical shortage list. Wholesaler allocation limits created uneven distribution, with some regions more affected than others.
• 2025: The launch of generic Budesonide/Formoterol inhalers, including Breyna (by Viatris) and authorized generics, began to relieve pressure on supply. More manufacturers entering the market expanded overall availability.
• 2026: Supply has largely stabilized. Generic options are more widely available, and brand-name Symbicort is stocked more consistently.

How Much Does Budesonide/Formoterol Cost in 2026?

Cost is a major factor for many patients, especially those without insurance or with high-deductible plans. Here's a snapshot of current pricing:

• Brand-name Symbicort: $350–$500 per inhaler (120 actuations) without insurance
• Generic Budesonide/Formoterol (Breyna, authorized generic): $150–$300 without insurance at retail price
• With discount cards (GoodRx, SingleCare): As low as $90–$150 for generic versions at participating pharmacies
• With the AstraZeneca Savings Card: Commercially insured patients may pay as little as $0 for brand-name Symbicort

If cost is a barrier, check out our complete guide to saving money on Budesonide/Formoterol, which covers coupons, discount programs, and patient assistance options.

New Options and Developments

A few developments are making it easier for patients in 2026:

Generic Competition Is Growing

The availability of generic Budesonide/Formoterol from multiple manufacturers has been a game-changer. Generics meet the same FDA standards for safety and effectiveness as brand-name Symbicort. With more companies making the product, the overall supply is more resilient to disruptions.

Medicare Cost Caps

Under the Inflation Reduction Act, Medicare Part D out-of-pocket costs have been capped. This means Medicare beneficiaries are paying less for inhalers like Budesonide/Formoterol than in previous years — a significant relief for older patients with COPD.

More Pharmacies Stocking Generics

As generic versions have become more established, a wider range of pharmacies now carry them. Many pharmacies that previously only stocked brand-name Symbicort have added generic options to their inventory.

How to Find Budesonide/Formoterol in Stock

If your usual pharmacy is out, here are your best options:

1. Use Medfinder — Search for Budesonide/Formoterol by zip code to see which nearby pharmacies have it available right now.
2. Try independent pharmacies — They often have different wholesaler relationships and may have stock when chains don't.
3. Ask about the generic — If your pharmacy is out of Symbicort, generic Budesonide/Formoterol or Breyna may be in stock (and cheaper).
4. Consider mail-order — Mail-order pharmacies often have more consistent supply and can ship a 90-day supply to your door.
5. Refill early — Don't wait until you're on your last few puffs. Start the refill process a few days early to give yourself a buffer.

For more detailed tips, see our guide on how to find Budesonide/Formoterol in stock near you.

What If You Can't Find It at All?

If Budesonide/Formoterol is truly unavailable in your area for an extended period, talk to your doctor about alternative ICS/LABA inhalers. Options like Advair (Fluticasone/Salmeterol), Breo Ellipta, and Dulera use similar mechanisms and can bridge the gap or serve as long-term replacements.

Never simply stop taking your maintenance inhaler without talking to your prescriber. Going without controller therapy increases your risk of asthma attacks or COPD flare-ups.

Final Thoughts

The Budesonide/Formoterol shortage that peaked in 2023–2024 has largely eased. Generic availability, increased manufacturing, and growing pharmacy stock have all helped. But localized gaps can still pop up, so it pays to be proactive about your refills.

If you're having trouble finding Budesonide/Formoterol right now, check Medfinder for real-time availability near you. And if cost is a concern, explore the savings options available in 2026.

Find Budesonide/Formoterol in stock near you →